📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis. (2012)

First Author: Chapman TM

Attributed to: Expansion of MRCTs Drug Discovery Group (DDG) funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmcl.2012.02.107

PubMed Identifier: 22469702

Publication URI: http://europepmc.org/abstract/MED/22469702

Type: Journal Article/Review

Volume: 22

Parent Publication: Bioorganic & medicinal chemistry letters

Issue: 9

ISSN: 0960-894X